{"id":"https://openalex.org/W3001273004","doi":"https://doi.org/10.1158/1535-7163.targ-19-a088","title":"Abstract A088: Novel anti-EGFR antibody-drug conjugate AVID100: A phase 2a trial in patients with EGFR-overexpressing advanced solid tumors","display_name":"Abstract A088: Novel anti-EGFR antibody-drug conjugate AVID100: A phase 2a trial in patients with EGFR-overexpressing advanced solid tumors","publication_year":2019,"publication_date":"2019-12-01","ids":{"openalex":"https://openalex.org/W3001273004","doi":"https://doi.org/10.1158/1535-7163.targ-19-a088","mag":"3001273004"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.targ-19-a088","doi":"https://doi.org/10.1158/1535-7163.targ-19-a088","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.targ-19-a088","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5035594574","display_name":"Jason M. Melear","orcid":"https://orcid.org/0009-0008-7943-8908","observed_orcids":["https://orcid.org/0009-0008-7943-8908"]},"institutions":[{"id":"https://openalex.org/I2800124591","display_name":"Texas Oncology","ror":"https://ror.org/02ketev28","country_code":"US","type":"facility","lineage":["https://openalex.org/I2800124591"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jason Melear","raw_affiliation_strings":["1Texas Oncology-Austin Midtown, Austin, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Texas Oncology-Austin Midtown, Austin, TX;","institution_ids":["https://openalex.org/I2800124591"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003770647","display_name":"Nehal J. Lakhani","orcid":"https://orcid.org/0009-0005-6327-0176","observed_orcids":["https://orcid.org/0009-0005-6327-0176"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nehal Lakhani","raw_affiliation_strings":["2START-Midwest, Grand Rapids, MI;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2START-Midwest, Grand Rapids, MI;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071432873","display_name":"Joyce O\u2019Shaughnessy","orcid":"https://orcid.org/0000-0002-2955-5523","observed_orcids":["https://orcid.org/0000-0002-2955-5523","https://orcid.org/0000-0001-6764-2807"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joyce A O'Shaughnessy","raw_affiliation_strings":["3Texas Oncology-Baylor, Dallas, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Texas Oncology-Baylor, Dallas, TX;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086433204","display_name":"Sharon T. Wilks","orcid":"https://orcid.org/0000-0003-2004-4273","observed_orcids":["https://orcid.org/0000-0003-2004-4273"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sharon T Wilks","raw_affiliation_strings":["4Texas Oncology-San Antonio Northeast, San Antonio, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Texas Oncology-San Antonio Northeast, San Antonio, TX;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100656048","display_name":"Saad A. Khan","orcid":"https://orcid.org/0000-0002-3440-9774","observed_orcids":["https://orcid.org/0000-0002-3440-9774"]},"institutions":[{"id":"https://openalex.org/I867280407","display_name":"The University of Texas Southwestern Medical Center","ror":"https://ror.org/05byvp690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I867280407"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Saad Khan","raw_affiliation_strings":["5UT Southwestern, Dallas, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5UT Southwestern, Dallas, TX;","institution_ids":["https://openalex.org/I867280407"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080415340","display_name":"Sree R Chandana","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sree R Chandana","raw_affiliation_strings":["2START-Midwest, Grand Rapids, MI;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2START-Midwest, Grand Rapids, MI;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060992997","display_name":"Anthony W. Tolcher","orcid":"https://orcid.org/0000-0002-6322-9721","observed_orcids":["https://orcid.org/0000-0002-6322-9721"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anthony W Tolcher","raw_affiliation_strings":["2START-Midwest, Grand Rapids, MI;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2START-Midwest, Grand Rapids, MI;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059997105","display_name":"Kyri P. Papadopoulos","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210119066","display_name":"South Texas Accelerated Research Therapeutics","ror":"https://ror.org/01scs7915","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210119066"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kyri P Papadopoulos","raw_affiliation_strings":["6START-San Antonio, San Antonio, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6START-San Antonio, San Antonio, TX;","institution_ids":["https://openalex.org/I4210119066"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079014717","display_name":"Yvette Cole","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210119066","display_name":"South Texas Accelerated Research Therapeutics","ror":"https://ror.org/01scs7915","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210119066"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yvette Cole","raw_affiliation_strings":["6START-San Antonio, San Antonio, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6START-San Antonio, San Antonio, TX;","institution_ids":["https://openalex.org/I4210119066"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058606655","display_name":"Karla Rivas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210119066","display_name":"South Texas Accelerated Research Therapeutics","ror":"https://ror.org/01scs7915","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210119066"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Karla Rivas","raw_affiliation_strings":["6START-San Antonio, San Antonio, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6START-San Antonio, San Antonio, TX;","institution_ids":["https://openalex.org/I4210119066"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Ria Ghosh","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ria Ghosh","raw_affiliation_strings":["7Forbius, Austin, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"7Forbius, Austin, TX;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036708021","display_name":"Sandra Sinclair","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sandra Sinclair","raw_affiliation_strings":["7Forbius, Austin, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"7Forbius, Austin, TX;","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Robert Lutz","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Robert Lutz","raw_affiliation_strings":["7Forbius, Austin, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"7Forbius, Austin, TX;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001736304","display_name":"Paul I. Nadler","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paul I Nadler","raw_affiliation_strings":["7Forbius, Austin, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"7Forbius, Austin, TX;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066473113","display_name":"Debra L. Wood","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Debra L Wood","raw_affiliation_strings":["7Forbius, Austin, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"7Forbius, Austin, TX;","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5023000705","display_name":"Barbara Ann Burtness","orcid":"https://orcid.org/0000-0003-4660-1859","observed_orcids":["https://orcid.org/0000-0003-4660-1859"]},"institutions":[{"id":"https://openalex.org/I2802730090","display_name":"Yale Cancer Center","ror":"https://ror.org/03j7sze86","country_code":"US","type":"facility","lineage":["https://openalex.org/I2802730090","https://openalex.org/I4210117499","https://openalex.org/I4210165192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Barbara Burtness","raw_affiliation_strings":["8Yale Cancer Center, New Haven, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"8Yale Cancer Center, New Haven, CT","institution_ids":["https://openalex.org/I2802730090"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"18","issue":"12_Supplement","first_page":"A088","last_page":"A088"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.7720000147819519,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.7720000147819519,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.21389999985694885,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.00430000014603138,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/egfr-overexpression","display_name":"EGFR overexpression","score":0.9679999947547913},{"id":"https://openalex.org/keywords/lung-squamous-cell-carcinoma","display_name":"lung squamous cell carcinoma","score":0.8759999871253967},{"id":"https://openalex.org/keywords/head-and-neck-squamous-cell-carcinoma","display_name":"head and neck squamous cell carcinoma","score":0.9879999756813049},{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.9990000128746033},{"id":"https://openalex.org/keywords/egfr-immunohistochemistry","display_name":"EGFR immunohistochemistry","score":0.7749999761581421},{"id":"https://openalex.org/keywords/biomarker-validation","display_name":"biomarker validation","score":0.5049999952316284},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.6819999814033508},{"id":"https://openalex.org/keywords/preliminary-efficacy","display_name":"preliminary efficacy","score":0.4740000069141388},{"id":"https://openalex.org/keywords/on-target-off-tumor-toxicity","display_name":"on-target off-tumor toxicity","score":0.7300000190734863}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8423051834106445},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.6078954935073853},{"id":"https://openalex.org/C2777325958","wikidata":"https://www.wikidata.org/wiki/Q1069596","display_name":"Antibody-drug conjugate","level":4,"score":0.5405904054641724},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.5311328768730164},{"id":"https://openalex.org/C2779998722","wikidata":"https://www.wikidata.org/wiki/Q420296","display_name":"Cetuximab","level":4,"score":0.5235005021095276},{"id":"https://openalex.org/C2777506169","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"EGFR inhibitors","level":4,"score":0.5125730037689209},{"id":"https://openalex.org/C2779984678","wikidata":"https://www.wikidata.org/wiki/Q2145898","display_name":"Response Evaluation Criteria in Solid Tumors","level":4,"score":0.49223700165748596},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.46819624304771423},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.46589195728302},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4636017084121704},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.42657119035720825},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.4019663333892822},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.3929179310798645},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.3457552194595337},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.34374523162841797},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.34338515996932983},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.23152059316635132},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.20081377029418945},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.126580148935318}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1535-7163.targ-19-a088","doi":"https://doi.org/10.1158/1535-7163.targ-19-a088","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.targ-19-a088","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.979200005531311}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2955316200","https://openalex.org/W2792333450","https://openalex.org/W2559956628","https://openalex.org/W4242753979","https://openalex.org/W7154692024","https://openalex.org/W2954367118","https://openalex.org/W4410813880","https://openalex.org/W2892197301","https://openalex.org/W4379283260","https://openalex.org/W4229081651"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Currently,":[2],"no":[3],"therapies":[4],"are":[5,244],"approved":[6],"specifically":[7],"for":[8,26,73,97,103,333,395],"EGFR-overexpressing":[9,516],"tumors.":[10],"AVID100":[11,111,130,172,391],"is":[12,43,160,262,271,399],"a":[13,46,117,274,282,444],"novel":[14,89,445],"anti-EGFR":[15,450,505],"antibody":[16,39],"drug":[17],"conjugate":[18,507],"(ADC,":[19],"DM1":[20],"payload)":[21],"that":[22,129],"was":[23,131,148,291,398],"rationally":[24],"designed":[25,161],"anti-tumor":[27],"efficacy":[28,115,170],"without":[29],"accompanying":[30],"on-target,":[31],"off-tumor":[32],"toxicity":[33],"by":[34,273,281],"employing":[35],"an":[36],"EGFR":[37,42,74,78,198,213,223,268,289,315,324,358,368,396],"function-blocking":[38,449],"moiety.":[40],"Although":[41],"overexpressed":[44],"in":[45,80,122,182,228,238,327,360,372,392,513],"multitude":[47],"of":[48,143,171,192,215,231,241,287,313,330,337,341,347,349,363,375,382,416,422,523],"malignancies":[49,127,191],"including":[50],"squamous":[51],"non-small":[52],"cell":[53],"lung":[54],"cancer":[55,65],"(sqNSCLC),":[56],"head":[57],"and":[58,62,90,96,116,168,195,205,209,259,307,343,366,379,402,407,427,454,531],"neck":[59],"carcinoma":[60],"(HNSCC)":[61],"triple-negative":[63],"breast":[64],"(TNBC),":[66],"historically":[67],"limited":[68],"activity":[69],"has":[70],"been":[71,412],"reported":[72],"monoclonal":[75],"antibodies":[76],"or":[77,187,234,370],"TKIs":[79],"unselected":[81],"patients.":[82,309],"This":[83,151],"emphasizes":[84],"the":[85,165,288,314,435,461,524],"need":[86],"to":[87,101,106,137,162,246,254,433],"develop":[88],"more":[91],"efficacious":[92],"agents":[93],"targeting":[94],"EGFR,":[95],"biomarker-":[98],"directed":[99],"approaches":[100],"enrich":[102],"patients":[104,123,183,211,221,393,410,514],"likely":[105],"respond.":[107],"In":[108],"pre-clinical":[109],"models,":[110],"showed":[112],"potent":[113],"anti-tumour":[114],"Phase":[118,156,387,439],"1":[119],"dose-escalation":[120],"study":[121,158],"with":[124,184,196,212,319,515],"advanced":[125,304,517],"solid":[126,189,518],"concluded":[128],"well":[132,218],"tolerated":[133],"at":[134,175,257,414,460],"doses":[135],"expected":[136],"be":[138,458],"therapeutically":[139],"active.":[140],"An":[141],"RP2D":[142],"220":[144],"mg/m2":[145],"(~6":[146],"mg/kg)":[147],"established.":[149],"Methods:":[150],"open-label,":[152],"multicenter,":[153],"multicohort,":[154],"prospective":[155,386,438],"2a":[157,388,440,511],"(NCT03094169)":[159],"further":[163],"evaluate":[164],"safety,":[166],"tolerability,":[167],"preliminary":[169],"when":[173],"administered":[174],"6":[176,266],"mg/kg":[177],"Q3W":[178],"per":[179],"iv":[180],"infusion":[181],"locally":[185],"advanced/unresectable":[186],"metastatic":[188],"tumor":[190,232,242,331,364,376],"epithelial":[193],"origin,":[194],"documented":[197],"over-expression.":[199],"Additional":[200],"endpoints":[201],"include":[202],"PK":[203],"profiling":[204],"exploratory":[206],"biomarkers.":[207],"sqNSCLC":[208,342],"HNSCC":[210,306,350,426],"IHC":[214,224,276,290,316],"3+":[216,226,325,359,371],"as":[217,219],"mTNBC":[220],"whose":[222],"shows":[225],"intensity":[227,237],"\u2265":[229,235,239,328,361,373],"50%":[230,329,362,374],"cells,":[233,243],"2+":[236],"75%":[240],"eligible":[245],"enroll.":[247],"Patients":[248],"must":[249],"have":[250],"measurable":[251],"disease":[252,260],"according":[253],"RECIST":[255],"v1.1":[256],"enrolment":[258],"status":[261],"assessed":[263,424],"radiographically":[264],"every":[265],"weeks.":[267],"over-expression":[269],"positivity":[270,326],"established":[272],"validated":[275],"assay":[277,317],"(DAKO":[278],"EGFRpharmDX)":[279],"conducted":[280,318],"central":[283],"laboratory.":[284],"Initial":[285,311],"validation":[286,312],"carried":[292],"out":[293,336,346,381],"retrospectively":[294,423],"on":[295,528],"archival":[296,320],"tissue":[297,321],"microarrays":[298],"(US":[299],"Biomax,":[300],"Derwood,":[301],"MD)":[302],"from":[303],"sqNSCLC,":[305,404,425],"TNBC":[308,353,409,428],"Results":[310],"samples":[322,339,354,430],"yielded":[323],"cells":[332,365,377],"30%":[334],"(32":[335],"105":[338],"tested)":[340],"22%":[344],"(31":[345],"140)":[348],"samples.":[351],"Among":[352],"tested,":[355],"6%":[356],"were":[357,431],"25%":[367],"2":[369],"(16":[378],"62":[380],"249,":[383],"respectively).":[384],"The":[385,437],"trial":[389,441,512],"assessing":[390,442],"selected":[394],"overexpression":[397],"actively":[400],"accruing":[401],"one":[403],"four":[405],"SCCHN":[406],"three":[408],"had":[411],"enrolled":[413],"time":[415],"writing.":[417],"Conclusions":[418],"A":[419,470,509],"significant":[420],"proportion":[421],"patient":[429],"found":[432],"overexpress":[434],"EGFR.":[436],"AVID100,":[443],"growth":[446],"factor":[447],"receptor":[448],"ADC,":[451],"remains":[452],"ongoing":[453],"updated":[455],"results":[456],"will":[457],"presented":[459],"meeting.":[462],"Citation":[463],"Format:":[464],"Jason":[465],"Melear,":[466],"Nehal":[467],"Lakhani,":[468],"Joyce":[469],"O'Shaughnessy,":[471],"Sharon":[472],"T":[473],"Wilks,":[474],"Saad":[475],"Khan,":[476],"Sree":[477],"R":[478],"Chandana,":[479],"Anthony":[480],"W":[481],"Tolcher,":[482],"Kyri":[483],"P":[484],"Papadopoulos,":[485],"Yvette":[486],"Cole,":[487],"Karla":[488],"Rivas,":[489],"Ria":[490],"Ghosh,":[491],"Sandra":[492],"Sinclair,":[493],"Robert":[494],"Lutz,":[495],"Paul":[496],"I":[497],"Nadler,":[498],"Debra":[499],"L":[500],"Wood,":[501],"Barbara":[502],"Burtness.":[503],"Novel":[504],"antibody-drug":[506],"AVID100:":[508],"phase":[510],"tumors":[519],"[abstract].":[520],"In:":[521],"Proceedings":[522],"AACR-NCI-EORTC":[525],"International":[526],"Conference":[527],"Molecular":[529],"Targets":[530],"Cancer":[532,543],"Therapeutics;":[533],"2019":[534],"Oct":[535],"26-30;":[536],"Boston,":[537],"MA.":[538],"Philadelphia":[539],"(PA):":[540],"AACR;":[541],"Mol":[542],"Ther":[544],"2019;18(12":[545],"Suppl):Abstract":[546],"nr":[547],"A088.":[548],"doi:10.1158/1535-7163.TARG-19-A088":[549]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1}],"updated_date":"2026-10-17T09:40:24.721904","created_date":"2020-01-30T00:00:00"}